A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma

Peer Review reports

Original Submission
13 Apr 2020	Submitted	Original manuscript
3 Jun 2020	Reviewed	Reviewer Report
8 Jul 2020	Reviewed	Reviewer Report
15 Sep 2020	Author responded	Author comments - Salvatore Paiella
Resubmission - Version 2
15 Sep 2020	Submitted	Manuscript version 2
Publishing
4 Feb 2021	Editorially accepted
16 Feb 2021	Article published	10.1186/s12885-021-07877-7

Back to article page